Adenosine A2A receptor antagonists

Details for Australian Patent Application No. 2008232690 (hide)

Owner King Pharmaceuticals Research And Development, Inc.

Inventors Moorman, Allan R.

Agent Pizzeys

Pub. Number AU-A-2008232690

PCT Pub. Number WO2008/121748

Priority 60/909,106 30.03.07 US; 12/056,423 27.03.08 US; 12/056,403 27.03.08 US

Filing date 28 March 2008

Wipo publication date 9 October 2008

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/121748 Priority application(s): WO2008/121748

10 December 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Oct 2009

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008232699-High expression clones of mammalian cells with fluorescent protein A or G

2008232684-Plastic pallet with snap-pins and associated method for making the same